156 related articles for article (PubMed ID: 32279226)
21. CIRCULATING THYROID-STIMULATING HORMONE RECEPTOR MESSENGER RNA AS A MARKER OF TUMOR AGGRESSIVENESS IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.
Aliyev A; Gupta M; Nasr C; Hatipoglu B; Milas M; Siperstein A; Berber E
Endocr Pract; 2015 Jul; 21(7):777-81. PubMed ID: 25786552
[TBL] [Abstract][Full Text] [Related]
22. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
[TBL] [Abstract][Full Text] [Related]
23. [Aberrant methylation of hMLH1 gene promoter in papillary thyroid cancer and its clinical significance].
Lu XX; Ge MH; Ling ZQ; Hu SS; Xu J; Zheng CM; Tan Z; Chen C
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):833-6. PubMed ID: 24447481
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological predictors of occult lateral neck lymph node metastasis in papillary thyroid cancer: A meta-analysis.
Zhan S; Luo D; Ge W; Zhang B; Wang T
Head Neck; 2019 Jul; 41(7):2441-2449. PubMed ID: 30938923
[TBL] [Abstract][Full Text] [Related]
25. Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
Huang M; Yan C; Xiao J; Wang T; Ling R
Diagn Pathol; 2019 Jul; 14(1):74. PubMed ID: 31300059
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: A systematic review and meta-analysis.
Ma B; Wang Y; Yang S; Ji Q
Int J Surg; 2016 Apr; 28():153-61. PubMed ID: 26944586
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological significance of loss of p27kip1 expression in papillary thyroid carcinoma.
Kim NY; Kim JH; Pyo JS; Jin Cho W
Int J Biol Markers; 2017 May; 32(2):e255-e259. PubMed ID: 27834461
[TBL] [Abstract][Full Text] [Related]
28. A Meta-analysis of Central Lymph Node Metastasis for Predicting Lateral Involvement in Papillary Thyroid Carcinoma.
Lan X; Sun W; Zhang H; Dong W; Wang Z; Zhang T
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):731-8. PubMed ID: 26307575
[TBL] [Abstract][Full Text] [Related]
29. Methylation of sodium iodide symporter promoter correlated with aggressiveness and metastasis in papillary thyroid carcinoma: a meta-analysis.
Zhao JY; Wang HJ; Wang HP; Yao JM; Wu XY; Shang HX; Zhang R; Zhu HG; Dong JJ; Liao L
Int J Clin Exp Med; 2015; 8(7):10731-8. PubMed ID: 26379865
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive DNA Methylation Profiling Identifies Novel Diagnostic Biomarkers for Thyroid Cancer.
Park JL; Jeon S; Seo EH; Bae DH; Jeong YM; Kim Y; Bae JS; Kim SK; Jung CK; Kim YS
Thyroid; 2020 Feb; 30(2):192-203. PubMed ID: 31797753
[No Abstract] [Full Text] [Related]
31. [Clinical analysis between trefoil factor 3 gene polymorphsims and susceptibility to papillary thyroid carcinoma].
Pei D; Xue G; Wu JF; Wang DM; Qin XJ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 33(10):926-931. PubMed ID: 31623036
[No Abstract] [Full Text] [Related]
32. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
Yan B; Hou Y; Chen D; He J; Jiang Y
Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
[TBL] [Abstract][Full Text] [Related]
33. Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.
Zhang Q; Liu SZ; Zhang Q; Guan YX; Chen QJ; Zhu QY
Cell Physiol Biochem; 2016; 38(2):763-76. PubMed ID: 26871894
[TBL] [Abstract][Full Text] [Related]
34. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathological significance of Golgi phosphoprotein 3 expression in papillary thyroid carcinoma].
Huang DH; Jin L; Xie WW; Lin Q; Chen X
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2831-2835. PubMed ID: 31550811
[No Abstract] [Full Text] [Related]
36. The role of two tumor foci for predicting central lymph node metastasis in papillary thyroid carcinoma: A meta-analysis.
Feng J; Gan X; Shen F; Cai W; Xu B
Int J Surg; 2018 Apr; 52():166-170. PubMed ID: 29481991
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Sun W; Lan X; Zhang H; Dong W; Wang Z; He L; Zhang T; Liu S
PLoS One; 2015; 10(10):e0139021. PubMed ID: 26431346
[TBL] [Abstract][Full Text] [Related]
38. Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma.
Zhou C; Li J; Wang Y; Xue S; Zhang Y
Oncol Lett; 2019 Jan; 17(1):183-194. PubMed ID: 30655754
[TBL] [Abstract][Full Text] [Related]
39. E-cadherin expression is associated with susceptibility and clinicopathological characteristics of thyroid cancer: A PRISMA-compliant meta-analysis.
Zhou C; Yang C; Chong D
Medicine (Baltimore); 2019 Jul; 98(30):e16187. PubMed ID: 31348230
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: Diagnosis of central and lateral compartment nodal metastases.
Zhao H; Li H
Eur J Radiol; 2019 Mar; 112():14-21. PubMed ID: 30777203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
